BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32289434)

  • 1. Tumor development in rats and cancer cachexia are reduced by treatment with botryosphaeran by increasing apoptosis and improving the metabolic profile.
    Geraldelli D; Ribeiro MC; Medeiros TC; Comiran PK; Martins KO; Oliveira MF; Oliveira GA; Dekker RFH; Barbosa-Dekker AM; Alegranci P; Queiroz EAIF
    Life Sci; 2020 Jul; 252():117608. PubMed ID: 32289434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botryosphaeran, a (1 → 3)(1 → 6)-β-D-glucan, reduces tumor development and cachexia syndrome in obese male rats by increasing insulin sensitivity and FOXO3a activity.
    Geraldelli D; Ribeiro MC; Medeiros TC; Comiran PK; Martins KO; Oliveira MF; Oliveira GA; Dekker RFH; Barbosa-Dekker AM; Alegranci P; Queiroz EAIF
    Int J Biol Macromol; 2020 Dec; 165(Pt A):985-994. PubMed ID: 32991890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botryosphaeran Attenuates Tumor Development and the Cancer Cachexia Syndrome in Walker-256 Tumor-Bearing Obese Rats and Improves the Metabolic and Hematological Profiles of These Rats.
    Comiran PK; Ribeiro MC; Silva JHG; Martins KO; Santos IA; Chiaradia AEF; Silva AZ; Dekker RFH; Barbosa-Dekker AM; Alegranci P; Queiroz EAIF
    Nutr Cancer; 2021; 73(7):1175-1192. PubMed ID: 32643421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botryosphaeran reduces obesity, hepatic steatosis, dyslipidaemia, insulin resistance and glucose intolerance in diet-induced obese rats.
    Silva AZ; Costa FPL; Souza IL; Ribeiro MC; Giordani MA; Queiroz DA; Luvizotto RAM; Nascimento AF; Bomfim GF; Sugizaki MM; Dekker RFH; Barbosa-Dekker AM; Queiroz EAIF
    Life Sci; 2018 Oct; 211():147-156. PubMed ID: 30227131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative and pro-apoptotic effects of three fungal exocellular β-glucans in MCF-7 breast cancer cells is mediated by oxidative stress, AMP-activated protein kinase (AMPK) and the Forkhead transcription factor, FOXO3a.
    Queiroz EA; Fortes ZB; da Cunha MA; Barbosa AM; Khaper N; Dekker RF
    Int J Biochem Cell Biol; 2015 Oct; 67():14-24. PubMed ID: 26255117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemic and Hypocholesterolemic Effects of Botryosphaeran from Botryosphaeria rhodina MAMB-05 in Diabetes-Induced and Hyperlipidemia Conditions in Rats.
    Miranda-Nantes CC; Fonseca EA; Zaia CT; Dekker RF; Khaper N; Castro IA; Barbosa AM
    Mycobiology; 2011 Sep; 39(3):187-93. PubMed ID: 22783102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant, anti-inflammatory and beneficial metabolic effects of botryosphaeran [(1→3)(1→6)-β-d-glucan] are responsible for its anti-tumour activity in experimental non-obese and obese rats bearing Walker-256 tumours.
    da Silva TP; Geraldelli D; Martins KO; Braga AJL; Rosa AP; Ferneda JMA; Bomfim GF; Barbosa-Dekker AM; Dekker RFH; Dias MC; Paim NP; Sinhorin VDG; de Queiroz EAIF
    Cell Biochem Funct; 2022 Feb; ():. PubMed ID: 35229356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo antimutagenic and antiatherogenic effects of the (1 → 3)(1 → 6)-β-d- glucan botryosphaeran.
    Silva-Sena GG; Malini M; Delarmelina JM; Dutra JCV; Gervásio SV; Leal MAS; Costa Pereira TM; Barbosa-Dekker AM; Dekker RFH; de Paula F; Batitucci MDCP
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Feb; 826():6-14. PubMed ID: 29412871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended treatment with (1→3)(1→6)-β-d-glucan (Botryosphaeran) reduces obesity and its comorbidities in high-fat/high-sugar diet-fed rats.
    Ribeiro MC; Silva AZD; Giordani MA; Lira C; Luvizotto RAM; Nascimento AF; Queiroz DA; Dekker RFH; Barbosa-Dekker AM; de Queiroz EAIF
    Cell Biochem Funct; 2022 Oct; 40(7):773-783. PubMed ID: 36111697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of gene expression and cell cycle by botryosphaeran, a (1→3)(1→6)-β-d-glucan in human lymphocytes.
    Malini M; Souza MF; Oliveira MT; Antunes LM; Figueiredo SG; Barbosa AM; Dekker RF; Cólus IM
    Int J Biol Macromol; 2015; 77():214-21. PubMed ID: 25795388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticlastogenic activity exhibited by botryosphaeran, a new exopolysaccharide produced by Botryosphaeria rhodina MAMB-05.
    Miranda CC; Dekker RF; Serpeloni JM; Fonseca EA; Cólus IM; Barbosa AM
    Int J Biol Macromol; 2008 Mar; 42(2):172-7. PubMed ID: 18022685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of botryosphaeran [(1 → 3)(1 → 6)-β-d-glucan] reduces inflammation through modulation of leukocytes and has limited effect on inflammatory nociception.
    Silva NA; Pereira BG; Santos JA; Guarnier FA; Barbosa-Dekker AM; Dekker RFH; Kassuya CAL; Bernardes SS
    Cell Biochem Funct; 2022 Aug; 40(6):578-588. PubMed ID: 35788958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutrition and Cancercapsaicin Treatment Reduces Tumor Growth, Tumor Cell Proliferation Ex Vivo and Partially Reverses Cancer Cachexia in Walker 256 Tumor-Bearing Rats.
    Ricardo de Brito Bello S; Naliwaiko K; Vicentini MS; Rossetti FX; Claudio Fernandes L; Messias-Reason IJ
    Nutr Cancer; 2019; 71(1):111-117. PubMed ID: 30741012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consumption of latex from Euphorbia tirucalli L. promotes a reduction of tumor growth and cachexia, and immunomodulation in Walker 256 tumor-bearing rats.
    Martins CG; Appel MH; Coutinho DSS; Soares IP; Fischer S; de Oliveira BC; Fachi MM; Pontarolo R; Bonatto SJR; Fernandes LC; Iagher F; de Souza LM
    J Ethnopharmacol; 2020 Jun; 255():112722. PubMed ID: 32114165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free-radical scavenging properties and antioxidant activities of botryosphaeran and some other β-D-glucans.
    Giese EC; Gascon J; Anzelmo G; Barbosa AM; da Cunha MA; Dekker RF
    Int J Biol Macromol; 2015 Jan; 72():125-30. PubMed ID: 25128096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer cachexia and tumor growth reduction in Walker 256 tumor-bearing rats supplemented with N-3 polyunsaturated fatty acids for one generation.
    Togni V; Ota CC; Folador A; Júnior OT; Aikawa J; Yamazaki RK; Freitas FA; Longo R; Martins EF; Calder PC; Curi R; Fernandes LC
    Nutr Cancer; 2003; 46(1):52-8. PubMed ID: 12925304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin reduces the Walker-256 tumor development in obese-MSG rats via AMPK and FOXO3a.
    de Queiroz EA; Akamine EH; de Carvalho MH; Sampaio SC; Fortes ZB
    Life Sci; 2015 Jan; 121():78-87. PubMed ID: 25497710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cachexia induced by Walker 256 tumor growth causes rat lymphocyte death.
    de Lima TM; Lima MM; Almeida DC; Mendonça JR; Curi R
    Cancer Immunol Immunother; 2005 Feb; 54(2):179-86. PubMed ID: 15378280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic supplementation with shark liver oil for reducing tumor growth and cachexia in walker 256 tumor-bearing rats.
    Iagher F; de Brito Belo SR; Naliwaiko K; Franzói AM; de Brito GA; Yamazaki RK; Muritiba AL; Muehlmann LA; Steffani JA; Fernandes LC
    Nutr Cancer; 2011 Nov; 63(8):1307-15. PubMed ID: 21981555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro protective effects of botryosphaeran, a (1→3;1→6)-β-d-glucan, against mutagens in normal and tumor rodent cells.
    Kerche-Silva LE; Cólus IM; Malini M; Mori MP; Dekker RF; Barbosa-Dekker AM
    Mutat Res Genet Toxicol Environ Mutagen; 2017 Feb; 814():29-36. PubMed ID: 28137365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.